CONTRIBUTION OF CR3, CD11B/CD18 TO CYTOLYSIS BY HUMAN NK CELLS

被引:39
|
作者
KLEIN, E [1 ]
DIRENZO, L [1 ]
YEFENOF, E [1 ]
机构
[1] HADASSAH MED SCH, LAUTENBERG CTR GEN & TUMOR IMMUNOL, IL-91010 JERUSALEM, ISRAEL
关键词
D O I
10.1016/0161-5890(90)90041-W
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The complement receptor CR3 molecule functions in direct intercellular contacts mediated by its beta chain, CD18. Similarly to the Fc receptor (CD16), CR3 is a marker of human natural killer cells. We have shown that opsonization of NK targets with iC3b leads to their increased lytic sensitivity. Opsonization could be achieved by incubating certain B and T cells lines in human serum. The expression of CR2 was a prerequisite for C3 fragment fixation. The CR2 negative cell line, P3HR1 could be opsonized by incubation in human serum when induced to express the EBV envelope glycoprotein gp350. C3b or iC3b could also be deposited artificially on cell surfaces by chemical coupling to surface reactive antibodies. Similarly to the function of macrophages and monocytes, contact with opsonized targets exclusively through the iC3b binding site of CR3 did not seem to trigger NK function. We attempted to clarify the functional role of other CR3 ligands. The beta chain of the molecule, CD18, was essential to the NK effect. The NK targets did not seem to interact with the beta-glucan binding epitope on the alpha chain of CR3, CD11b. On the other hand, the cytolytic function could be enhanced through this epitope with the appropriate ligand.
引用
收藏
页码:1343 / 1347
页数:5
相关论文
共 50 条
  • [41] CR3 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and intercellular cleft formation.
    van Spriel, AB
    Leusen, JHW
    van Egmond, M
    van de Winkel, JGJ
    FASEB JOURNAL, 2000, 14 (06): : A960 - A960
  • [42] SELECTIVE MODULATION OF CD15S AND CR3 (CD11B/CD18) ON MONOCYTES AND NEUTROPHILS IN PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS
    CARRENO, MP
    STUART, S
    POIGNET, JL
    CHAUVEAU, P
    HAEFFNERCAVAILLON, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 438 - 438
  • [43] SUBPOPULATIONS OF B-LYMPHOCYTES AND T-LYMPHOCYTES EXPRESS CD11B/CD18 AND ARE CAPABLE OF CD11B/CD18 MEDIATED ADHESION
    ANDREW, DP
    BUTCHER, EC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 294 - 294
  • [44] CYTOPLASMIC TAILS OF HUMAN-COMPLEMENT RECEPTOR TYPE-3 (CR3, CD11B CD18) REGULATE LIGAND AVIDITY AND THE INTERNALIZATION OF OCCUPIED RECEPTORS
    RABB, H
    MICHISHITA, M
    SHARMA, CP
    BROWN, D
    ARNAOUT, MA
    JOURNAL OF IMMUNOLOGY, 1993, 151 (02): : 990 - 1002
  • [45] ROLE OF CD11A/CD18 AND CD11B/CD18 IN MIGRATION OF POLYMORPHONUCLEAR LEUKOCYTES TO INFLAMMATION IN THE RAT
    ISSEKUTZ, AC
    ISSEKUTZ, TB
    FASEB JOURNAL, 1992, 6 (04): : A1430 - A1430
  • [46] GROUP-B STREPTOCOCCUS-INDUCED NITRIC-OXIDE PRODUCTION IN MURINE MACROPHAGES IS CR3 (CD11B/CD18) DEPENDENT
    GOODRUM, KJ
    MCCORMICK, LL
    SCHNEIDER, B
    INFECTION AND IMMUNITY, 1994, 62 (08) : 3102 - 3107
  • [47] Mac-1 (CD18/CD11b, CR3)-dependent elastase cytotoxicity is required for tissue damage in a model of thrombohemorrhagic vasculitis
    Hirahashil, J
    Xiao, L
    Saffaripour, S
    Wagner, DD
    Shapiro, SD
    Mayadas, TN
    FASEB JOURNAL, 2004, 18 (04): : A389 - A389
  • [48] The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes:: activation-dependent up-regulation and regulatory function
    Wagner, C
    Hänsch, GM
    Stegmaier, S
    Denefleh, B
    Hug, F
    Schoels, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (04) : 1173 - 1180
  • [49] Human innate immune cells that engage soluble beta-1,3/1,6 glucans: Role for complement receptor 3 (CR3, CD11b/CD18)
    Vasilakos, John
    Bose, Nandita
    Chan, Anissa
    Danielson, Michael
    Dudney, Christine
    Elmasry, Natalie
    Gorden, Keith
    Guerrero, Faimola
    Magee, Andy
    Maristany, Carolyn
    Walsh, Richard
    Will, Paul
    Wurst, Lindsay
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [50] INVESTIGATION OF THE COMPLEMENT RECEPTOR-3 (CD11B/CD18) IN HUMAN RECTAL EPITHELIUM
    HUSSAIN, LA
    KELLY, CG
    RODIN, A
    JOURDAN, M
    LEHNER, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 102 (02): : 384 - 388